Latest / Community Health Media
Dr. Gregory Vidal & Dr. Nusayba Bagegni - Is HER2+ Metastatic Breast Cancer Curable? DESTINY-Breast09, Patina & What Comes Next
Recorded live with Drs. Gregory Vidal and Nusayba Bagegni, this in-depth conversation tackles one of the most provocative questions in HER2-positive metastatic breast cancer today: are we finally approaching cure?
The discussion spans more than a decade of progress — from the CLEOPATRA regimen and its long tail of durable responders to the practice-changing data from DESTINY-Breast09 showing a 40-month progression-free survival with T-DXd plus pertuzumab.
The panel explores how Patina, HER2CLIMB-05, endocrine therapy integration, CNS disease, and patient-specific risk factors are reshaping…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.